...
srrk-img

Scholar Rock Holding Corp, Common Stock

SRRK

NSQ

$41.65

-$2

(-4.58%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.09B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
335.32K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.48
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.76 L
$46.19 H
$41.65

About Scholar Rock Holding Corp, Common Stock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSRRKSectorS&P500
1-Week Return-1.95%-3.39%0.2%
1-Month Return65.47%-1.92%2.72%
3-Month Return429.73%-10.54%7.31%
6-Month Return397.15%-4.47%10.44%
1-Year Return143.18%4.06%27.53%
3-Year Return73.7%0.94%30.88%
5-Year Return280.23%36.67%89.21%
10-Year Return181.61%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue20.49M15.40M18.82M33.19M-[{"date":"2019-12-31","value":61.74,"profit":true},{"date":"2020-12-31","value":46.4,"profit":true},{"date":"2021-12-31","value":56.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue54.22M74.06M9.02M9.88M2.84M[{"date":"2019-12-31","value":73.2,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":12.18,"profit":true},{"date":"2022-12-31","value":13.35,"profit":true},{"date":"2023-12-31","value":3.84,"profit":true}]
Gross Profit20.49M15.40M9.79M33.19M(2.84M)[{"date":"2019-12-31","value":61.74,"profit":true},{"date":"2020-12-31","value":46.4,"profit":true},{"date":"2021-12-31","value":29.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-8.57,"profit":false}]
Gross Margin100.00%100.00%52.04%100.00%-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses75.03M102.28M148.74M167.56M171.29M[{"date":"2019-12-31","value":43.8,"profit":true},{"date":"2020-12-31","value":59.71,"profit":true},{"date":"2021-12-31","value":86.83,"profit":true},{"date":"2022-12-31","value":97.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(54.54M)(86.88M)(129.92M)(134.37M)(171.29M)[{"date":"2019-12-31","value":-5454200000,"profit":false},{"date":"2020-12-31","value":-8687800000,"profit":false},{"date":"2021-12-31","value":-12992100000,"profit":false},{"date":"2022-12-31","value":-13437000000,"profit":false},{"date":"2023-12-31","value":-17129500000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(51.00M)(86.48M)(131.80M)(134.50M)(165.79M)[{"date":"2019-12-31","value":-5100000000,"profit":false},{"date":"2020-12-31","value":-8648300000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false}]
Income Taxes(1.30M)(1.49M)2.39M(2.85M)2.68M[{"date":"2019-12-31","value":-48.69,"profit":false},{"date":"2020-12-31","value":-55.72,"profit":false},{"date":"2021-12-31","value":89.33,"profit":true},{"date":"2022-12-31","value":-106.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(51.00M)(86.48M)(131.80M)(134.50M)(158.92M)[{"date":"2019-12-31","value":-5100000000,"profit":false},{"date":"2020-12-31","value":-8648300000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13450200000,"profit":false},{"date":"2023-12-31","value":-15891800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(49.70M)(84.99M)(131.80M)(131.65M)(165.79M)[{"date":"2019-12-31","value":-4969700000,"profit":false},{"date":"2020-12-31","value":-8499200000,"profit":false},{"date":"2021-12-31","value":-13179900000,"profit":false},{"date":"2022-12-31","value":-13164800000,"profit":false},{"date":"2023-12-31","value":-16578900000,"profit":false}]
EPS (Diluted)(1.85)(2.81)(3.59)(2.28)(1.99)[{"date":"2019-12-31","value":-185,"profit":false},{"date":"2020-12-31","value":-281,"profit":false},{"date":"2021-12-31","value":-359,"profit":false},{"date":"2022-12-31","value":-228,"profit":false},{"date":"2023-12-31","value":-199,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SRRK
Cash Ratio 3.53
Current Ratio 3.88

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SRRK
ROA (LTM) -67.10%
ROE (LTM) -183.07%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SRRK
Debt Ratio Lower is generally better. Negative is bad. 0.56
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.44

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SRRK
Trailing PE NM
Forward PE NM
P/S (TTM) 13.14
P/B 50.68
Price/FCF NM
EV/R 8.22
EV/Ebitda NM

FAQs

What is Scholar Rock Holding Corp share price today?

Scholar Rock Holding Corp (SRRK) share price today is $41.65

Can Indians buy Scholar Rock Holding Corp shares?

Yes, Indians can buy shares of Scholar Rock Holding Corp (SRRK) on Vested. To buy Scholar Rock Holding Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SRRK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scholar Rock Holding Corp be purchased?

Yes, you can purchase fractional shares of Scholar Rock Holding Corp (SRRK) via the Vested app. You can start investing in Scholar Rock Holding Corp (SRRK) with a minimum investment of $1.

How to invest in Scholar Rock Holding Corp shares from India?

You can invest in shares of Scholar Rock Holding Corp (SRRK) via Vested in three simple steps:

  • Click on Sign Up or Invest in SRRK stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scholar Rock Holding Corp shares
What is Scholar Rock Holding Corp 52-week high and low stock price?

The 52-week high price of Scholar Rock Holding Corp (SRRK) is $46.19. The 52-week low price of Scholar Rock Holding Corp (SRRK) is $6.76.

What is Scholar Rock Holding Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Scholar Rock Holding Corp (SRRK) is

What is Scholar Rock Holding Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scholar Rock Holding Corp (SRRK) is 50.68

What is Scholar Rock Holding Corp dividend yield?

The dividend yield of Scholar Rock Holding Corp (SRRK) is 0.00%

What is the Market Cap of Scholar Rock Holding Corp?

The market capitalization of Scholar Rock Holding Corp (SRRK) is $4.09B

What is Scholar Rock Holding Corp’s stock symbol?

The stock symbol (or ticker) of Scholar Rock Holding Corp is SRRK

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top